BioCentury
ARTICLE | Clinical News

AVE0675: Phase I start

February 26, 2007 8:00 AM UTC

SAN will start a Phase I trial of inhaled AVE0675. In January, the FDA lifted a clinical hold that had been placed on the IND in 2005. SAN licensed rights to four TLR programs, including AVE0675, from...